Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion type Assertion NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_head.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion description "[We used enzyme-linked immunosorbent assays (ELISAs) to measure the cytokine interleukin-17A (IL-17A) in the serum of ALS patients (n = 32; 28 sporadic ALS (sALS) and 4 familial ALS (fALS)) and control subjects (n = 14; 10 healthy subjects and 4 with autoimmune disorders).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_provenance.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion evidence source_evidence_literature NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_provenance.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion SIO_000772 21062492 NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_provenance.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion wasDerivedFrom befree-2016 NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_provenance.
- NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_assertion wasGeneratedBy ECO_0000203 NP851343.RAnhnwcuN25rH4qPd_yRtiypMedLZ1f18aflIO_gbwp-w130_provenance.